Pregabalin drug classification?

Pregabalin – Drug Classification Overview

| Category | Details |
|----------|---------|
| Drug class | Gabapentinoid (often grouped with anticonvulsants) |
| Mechanism of action | Binds the α2δ subunit of voltage‑gated calcium channels, reducing excitatory neurotransmitter release (no direct GABA activity) |
| Therapeutic uses | • Partial‑onset seizures (as adjunct therapy)
• Neuropathic pain (diabetic, post‑herpetic, spinal cord injury, etc.)
• Fibromyalgia
• Generalized anxiety disorder (off‑label in many regions) |
| ATC code | N02AX02 – Anticonvulsants, gabapentinoids (N02A = Anticonvulsants; X02 = Pregabalin) |
| Common brand names | Lyrica, Lyrica® (others in various markets) |
| Key pharmacologic profile | • Lipophilic, low‑dose‑dependent CNS penetration
• Not metabolized significantly by CYP enzymes (low drug‑drug interaction risk)
• Eliminated primarily by unchanged renal excretion (dose adjustments in renal impairment) |

Bottom line: Pregabalin is classified as a gabapentinoid, an anticonvulsant drug that also serves as an analgesic and anxiolytic agent. It’s part of the broader anticonvulsant group (ATC N02A) but has a unique mechanism involving calcium‑channel modulation rather than direct GABA action.